To achieve capital growth through investing in high growth, development stage biotechnology companies.
Find out MoreInt.biotech. Share Price | |
---|---|
Price | 646.00 |
Bid | 644.00 |
Ask | 654.00 |
Change | -8.00 (-1.22%) |
Volume | 46,176 |
Open | 646.00 |
High | 648.00 |
Low | 646.00 |
Prev. Close | 654.00 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 37.31m |
Market Capitalisation | £241.02m |
Market Size | 750 |
52 Week High | 704.00 |
52 Week High Date | 28-Feb-2024 |
52 Week Low | 548.00 |
52 Week Low Date | 27-Oct-2023 |
# Trades | 35 |
---|---|
Vol. Sold | 19,937 |
Sold Value | £129.42k |
Vol. Bought | 21,239 |
Bought Value | £138.35k |
PE Ratio | 38.47528 |
Earnings | 16.79 |
Dividend | 28.20 |
Yield | 4.365% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
02-Jul-24 | 16:35:02 | 646.00 | 8 | Sell* | 644.00 | 654.00 | 51.68 | UT Uncrossing Trade |
02-Jul-24 | 16:28:56 | 648.00 | 102 | Sell* | 648.00 | 656.00 | 660.96 | A Automatic Execution |
02-Jul-24 | 15:57:08 | 649.193 | 2,687 | Sell* | 646.00 | 654.00 | 17.44k | O Ordinary |
02-Jul-24 | 15:35:17 | 647.20 | 1,350 | Sell* | 644.00 | 652.00 | 8,737 | O Ordinary |
02-Jul-24 | 15:33:34 | 647.1852 | 700 | Sell* | 644.00 | 652.00 | 4,530 | O Ordinary |
02-Jul-24 | 15:30:43 | 647.1928 | 747 | Sell* | 644.00 | 652.00 | 4,835 | O Ordinary |
02-Jul-24 | 15:21:44 | 650.00 | 15,000 | Buy* | 644.00 | 652.00 | 97.50k | O Ordinary |
02-Jul-24 | 15:21:20 | 646.00 | 400 | Buy* | 642.00 | 646.00 | 2,584 | A Automatic Execution |
02-Jul-24 | 15:20:59 | 647.20 | 1,200 | Sell* | 644.00 | 652.00 | 7,766 | O Ordinary |
02-Jul-24 | 15:04:01 | 647.1904 | 75 | Sell* | 644.00 | 652.00 | 485.39 | O Ordinary |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
07-Nov-23 | 07-Nov-23 | Buy | Caroline Gulliver held the position of Independent Non-Executive Director at the time of this trade.Caroline Gulliver | 573.15 | GBX | 2,500 | 17,000 |
04-Aug-23 | 03-Aug-23 | Buy | Patrick Magee held the position of Independent Non-Executive Director at the time of this trade.Patrick Magee | 632.00 | GBX | 1,500 | 11,500 |
03-Aug-23 | 03-Aug-23 | Buy | Katherine Cornish-Bowden held the position of Senior Independent Director at the time of this trade.Katherine Cornish-Bowden | 633.18 | GBX | 1,500 | 12,500 |
11-May-22 | 11-May-22 | Buy | Patrick Maxwell held the position of Independent Non-Executive Director at the time of this trade.Patrick Maxwell | 589.35 | GBX | 3,725 | 3,725 |
01-Apr-22 | 01-Apr-22 | Buy | Patrick Magee held the position of Independent Non-Executive Director at the time of this trade.Patrick Magee | 633.00 | GBX | 2,500 | 10,000 |